뉴스벤징가
Femasys Secures FDA Pathway for Non-Surgical Contraceptive
· 발표
기사 요약
FDA clears modular PMA pathway for Femasys' FemBloc, an investigational non-surgical permanent birth control device for women in the US.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
FDA clears modular PMA pathway for Femasys' FemBloc, an investigational non-surgical permanent birth control device for women in the US.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…